188 related articles for article (PubMed ID: 8397726)
1. Gamma-hydroxybutyric acid for treatment of opiate withdrawal syndrome.
Gallimberti L; Cibin M; Pagnin P; Sabbion R; Pani PP; Pirastu R; Ferrara SD; Gessa GL
Neuropsychopharmacology; 1993 Aug; 9(1):77-81. PubMed ID: 8397726
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy of gamma-hydroxybutyric acid in treatment of opiate withdrawal.
Gallimberti L; Schifano F; Forza G; Miconi L; Ferrara SD
Eur Arch Psychiatry Clin Neurosci; 1994; 244(3):113-4. PubMed ID: 7803523
[TBL] [Abstract][Full Text] [Related]
3. Effects of gamma-hydroxybutyric acid (GHB) in opioid-dependent patients.
Rosen MI; Pearsall HR; Woods SW; Kosten TR
J Subst Abuse Treat; 1997; 14(2):149-54. PubMed ID: 9258859
[TBL] [Abstract][Full Text] [Related]
4. The effect of gamma-hydroxybutyric acid on naloxone-precipitated opiate withdrawal.
Rosen MI; Pearsall HR; Woods SW; Kosten TR
Neuropsychopharmacology; 1996 Mar; 14(3):187-93. PubMed ID: 8866702
[TBL] [Abstract][Full Text] [Related]
5. Fatality due to gamma-hydroxybutyric acid (GHB) and heroin intoxication.
Ferrara SD; Tedeschi L; Frison G; Rossi A
J Forensic Sci; 1995 May; 40(3):501-4. PubMed ID: 7782758
[TBL] [Abstract][Full Text] [Related]
6. Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome.
Gallimberti L; Canton G; Gentile N; Ferri M; Cibin M; Ferrara SD; Fadda F; Gessa GL
Lancet; 1989 Sep; 2(8666):787-9. PubMed ID: 2571021
[TBL] [Abstract][Full Text] [Related]
7. Choice between heroin and food in nondependent and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine, and methadone.
Negus SS
J Pharmacol Exp Ther; 2006 May; 317(2):711-23. PubMed ID: 16456085
[TBL] [Abstract][Full Text] [Related]
8. [Is premature termination of opiate detoxification due to intensive withdrawal or craving?].
Scherbaum N; Heppekausen K; Rist F
Fortschr Neurol Psychiatr; 2004 Jan; 72(1):14-20. PubMed ID: 14745685
[TBL] [Abstract][Full Text] [Related]
9. Sodium Oxybate Therapy for Alcohol Withdrawal Syndrome and Keeping of Alcohol Abstinence.
Mannucci C; Pichini S; Spagnolo EV; Calapai F; Gangemi S; Navarra M; Calapai G
Curr Drug Metab; 2018; 19(13):1056-1064. PubMed ID: 29219048
[TBL] [Abstract][Full Text] [Related]
10. Clinical comparison of propoxyphene napsylate and methadone in the treatment of opiate dependence.
Wang RI; Kochar C; Hasegawa AT; Roh BL
NIDA Res Monogr; 1982 Apr; 41():253-60. PubMed ID: 6126814
[TBL] [Abstract][Full Text] [Related]
11. Effects of buspirone in withdrawal from opiates.
Rose JS; Branchey M; Wallach L; Buydens-Branchey L
Am J Addict; 2003; 12(3):253-9. PubMed ID: 12851021
[TBL] [Abstract][Full Text] [Related]
12. The effectiveness of combined naloxone/lofexidine in opiate detoxification: results from a double-blind randomized and placebo-controlled trial.
Beswick T; Best D; Bearn J; Gossop M; Rees S; Strang J
Am J Addict; 2003; 12(4):295-305. PubMed ID: 14504022
[TBL] [Abstract][Full Text] [Related]
13. GHB ameliorates naloxone-induced conditioned place aversion and physical aspects of morphine withdrawal in mice.
Maldonado C; RodrÃguez-Arias M; Aguilar MA; Miñarro J
Psychopharmacology (Berl); 2004 Dec; 177(1-2):130-40. PubMed ID: 15179545
[TBL] [Abstract][Full Text] [Related]
14. Development of buprenorphine for the treatment of opioid dependence.
Johnson RE; Fudala PJ
NIDA Res Monogr; 1992; 121():120-41. PubMed ID: 1383825
[TBL] [Abstract][Full Text] [Related]
15. [Gamma-hydroxybutyric acid (GHB) dependence and the GHB withdrawal syndrome: diagnosis and treatment].
van Noorden MS; Kamal R; de Jong CA; Vergouwen AC; Zitman FG
Ned Tijdschr Geneeskd; 2010; 154():A1286. PubMed ID: 21040601
[TBL] [Abstract][Full Text] [Related]
16. Noradrenergic hyperactivity in opiate withdrawal supported by clonidine reversal of opiate withdrawal.
Gold MS; Redmond DE; Kleber HD
Am J Psychiatry; 1979 Jan; 136(1):100-2. PubMed ID: 364997
[No Abstract] [Full Text] [Related]
17. Gamma-hydroxybutyric acid in the treatment of alcohol and heroin dependence.
Gallimberti L; Spella MR; Soncini CA; Gessa GL
Alcohol; 2000 Apr; 20(3):257-62. PubMed ID: 10869867
[TBL] [Abstract][Full Text] [Related]
18. The abrupt cessation of therapeutically administered sodium oxybate (GHB) does not cause withdrawal symptoms.
J Toxicol Clin Toxicol; 2003; 41(2):131-5. PubMed ID: 12733850
[TBL] [Abstract][Full Text] [Related]
19. Long-term methadone maintenance reduces protracted symptoms of heroin abstinence and cue-induced craving in Chinese heroin abusers.
Shi J; Zhao LY; Epstein DH; Zhang XL; Lu L
Pharmacol Biochem Behav; 2007 May; 87(1):141-5. PubMed ID: 17532034
[TBL] [Abstract][Full Text] [Related]
20. Tramadol versus methadone for treatment of opiate withdrawal: a double-blind, randomized, clinical trial.
Zarghami M; Masoum B; Shiran MR
J Addict Dis; 2012; 31(2):112-7. PubMed ID: 22540433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
